← Back to Search

Behavioural Intervention

Acceptance and Commitment Therapy Workshop for Obesity

N/A

Recruiting

Research Sponsored by University of Alabama at Birmingham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Must not have

Recent use of prescription medication for weight loss

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 1 month

Awards & highlights

No Placebo-Only Group

Summary

This trial will investigate whether a 4-hour workshop can help women with obesity adopt and maintain healthy lifestyle behaviors. Researchers will compare an intervention group to a control group.

Who is the study for?

This trial is for women with obesity (BMI >30.0 kg/m2) who can read and speak English and live within 50 miles of the University of Alabama at Birmingham. It's not for those on weight loss meds, with eating disorders or major mood disorders, in other weight programs, or who've had recent significant weight changes.

What is being tested?

Researchers are testing if a single 4-hour Acceptance and Commitment Therapy (ACT) workshop can help women with obesity adopt healthier lifestyles. They'll look at psychological factors and actual changes in diet and activity by comparing an active group to a waitlist control group over one month.

What are the potential side effects?

Since this intervention involves therapy rather than medication, typical medical side effects aren't expected. Participants may experience emotional discomfort when discussing personal issues related to their lifestyle behaviors.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have recently used prescription medication to lose weight.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 1 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 1 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change from baseline in distress tolerance at 1 month

Change from baseline in distress tolerance at Week 1

Change from baseline in psychological flexibility at 1 month

+3 more

Secondary study objectives

Change from baseline in body image at Month 1

Change from baseline in body image at Week 1

Change from baseline in body weight at 1 month

+9 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

Participants in the intervention group will receive the ACT workshop

Group II: Waitlist ControlActive Control1 Intervention

Participants in the waitlist control group will not receive the intervention until all members of the intervention group have received the workshop. Once all members of the intervention group have received the workshop, participants in the waitlist control group will be able to receive the workshop if they so desire.

0 / 1Eligibility criteria met